Supplementary Figure 5 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma

Supplementary Figure 5 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma

<p>Supplementary Figure 5: Single-cell RNA Sequencing and IHC examination of ALK in human neural development and immature neural cells. A. 2D representation of human brain cell subtypes (48 samples) during cortex development using a single cell RNA-seq atlas (cortex-dev.cells.ucsc.edu) shows t...

Disgrifiad llawn

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awdur:	Anne-Florence Blandin (15056366) (author)
Awduron Eraill:	Ross Giglio (15056369) (author), Maya Srikanth Graham (15056372) (author), Guadalupe Garcia (15056375) (author), Seth Malinowski (15056378) (author), Jared K. Woods (15056381) (author), Shakti Ramkissoon (15056384) (author), Lori Ramkissoon (15056387) (author), Frank Dubois (15056390) (author), Kathleen Schoolcraft (15056393) (author), Jessica Tsai (15056396) (author), Dayle Wang (15056399) (author), Robert Jones (15056402) (author), Jayne Vogelzang (15056405) (author), Kristine Pelton (15056408) (author), Sarah Becker (15056411) (author), Fiona Watkinson (15056414) (author), Claire Sinai (15056417) (author), Elizabeth F. Cohen (15056420) (author), Matthew A. Booker (15056423) (author), Michael Y. Tolstorukov (15056426) (author), Veerle Haemels (15056429) (author), Liliana Goumnerova (15056432) (author), Karen Wright (15056435) (author), Mark Kieran (15056438) (author), Katie Fehnel (15056441) (author), David Reardon (15056444) (author), Arnault Tauziede-Espariat (15056447) (author), Rishi Lulla (15056450) (author), Benjamin Carcamo (15056453) (author), Stanley Chaleff (15056456) (author), Alain Charest (15056459) (author), Frederik De Smet (14957559) (author), Azra H. Ligon (15056462) (author), Adrian Dubuc (15056465) (author), Melanie Pages (15056468) (author), Pascale Varlet (15056471) (author), Patrick Y. Wen (15056474) (author), Brian M. Alexander (15019467) (author), Susan Chi (15056477) (author), Sanda Alexandrescu (9122099) (author), Ralf Kittler (14864988) (author), Robert Bachoo (15056480) (author), Pratiti Bandopadhayay (15056483) (author), Rameen Beroukhim (15056486) (author), Keith L. Ligon (14958845) (author)
Cyhoeddwyd:	2025
Pynciau:	Cancer Cancer Biology Molecular and Cellular Biology Cancer Detection and Diagnosis Therapeutic Research and Development Methods and Technology Biomarkers Cell Signaling Receptors CNS Cancers Gliomas, Glioblastomas Drug Targets Protein kinase & phosphatase drug targets Oncogenes & Tumor Suppressors Oncogenes Pediatric Cancers Preclinical Models Xenograft models
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg

Supplementary Figure 1 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
gan: Anne-Florence Blandin (15056366)
Cyhoeddwyd: (2025)

Supplementary Figure 2 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
gan: Anne-Florence Blandin (15056366)
Cyhoeddwyd: (2025)

Supplementary Figure 3 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
gan: Anne-Florence Blandin (15056366)
Cyhoeddwyd: (2025)

Supplementary Figure 4 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
gan: Anne-Florence Blandin (15056366)
Cyhoeddwyd: (2025)

Supplementary Figure 6 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
gan: Anne-Florence Blandin (15056366)
Cyhoeddwyd: (2025)

Supplementary Tables 1-8 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
gan: Anne-Florence Blandin (15056366)
Cyhoeddwyd: (2025)

Supplemental Data File S3 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
gan: Katie E. Hebron (15046889)
Cyhoeddwyd: (2025)

Supplementary Data File S1 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
gan: Katie E. Hebron (15046889)
Cyhoeddwyd: (2025)

Supplementary Data File S2 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
gan: Katie E. Hebron (15046889)
Cyhoeddwyd: (2025)

Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
gan: Katie E. Hebron (15046889)
Cyhoeddwyd: (2025)

Supplementary Data File S7 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
gan: Katie E. Hebron (15046889)
Cyhoeddwyd: (2025)

Supplementary Data File S8 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
gan: Katie E. Hebron (15046889)
Cyhoeddwyd: (2025)

Supplementary Data File S9 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
gan: Katie E. Hebron (15046889)
Cyhoeddwyd: (2025)

Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
gan: Ana Vujovic (15207479)
Cyhoeddwyd: (2025)

Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
gan: Ana Vujovic (15207479)
Cyhoeddwyd: (2025)

Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
gan: Ana Vujovic (15207479)
Cyhoeddwyd: (2025)

Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
gan: Ana Vujovic (15207479)
Cyhoeddwyd: (2025)

Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
gan: Ana Vujovic (15207479)
Cyhoeddwyd: (2025)

Supplementary Table S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
gan: Ana Vujovic (15207479)
Cyhoeddwyd: (2025)

Supplementary Table S7 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
gan: Ana Vujovic (15207479)
Cyhoeddwyd: (2025)

Supplementary Table S8 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
gan: Ana Vujovic (15207479)
Cyhoeddwyd: (2025)

Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
gan: Ana Vujovic (15207479)
Cyhoeddwyd: (2025)

Figure S1 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
gan: Yuanqing Ma (15052437)
Cyhoeddwyd: (2025)

Figure S2 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
gan: Yuanqing Ma (15052437)
Cyhoeddwyd: (2025)

Figure S3 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
gan: Yuanqing Ma (15052437)
Cyhoeddwyd: (2025)

Figure S4 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
gan: Yuanqing Ma (15052437)
Cyhoeddwyd: (2025)

Figure S5 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
gan: Yuanqing Ma (15052437)
Cyhoeddwyd: (2025)

Figure S6 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
gan: Yuanqing Ma (15052437)
Cyhoeddwyd: (2025)

Figure S7 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
gan: Yuanqing Ma (15052437)
Cyhoeddwyd: (2025)

Figure S8 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
gan: Yuanqing Ma (15052437)
Cyhoeddwyd: (2025)

Supplementary Tables S1-14 from Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple <i>PIK3CA</i> Mutations
gan: Smruthy Sivakumar (15053536)
Cyhoeddwyd: (2025)

Supplementary Table S1 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
gan: Clare F. Malone (14960925)
Cyhoeddwyd: (2025)

Supplementary Table S2 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
gan: Clare F. Malone (14960925)
Cyhoeddwyd: (2025)

Supplementary Table S3 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
gan: Clare F. Malone (14960925)
Cyhoeddwyd: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
gan: Feng Wang (44414)
Cyhoeddwyd: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
gan: Feng Wang (44414)
Cyhoeddwyd: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
gan: Feng Wang (44414)
Cyhoeddwyd: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
gan: Feng Wang (44414)
Cyhoeddwyd: (2025)

Figure 1 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
gan: Nicholas T. Younger (14956251)
Cyhoeddwyd: (2025)

Figure 2 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
gan: Nicholas T. Younger (14956251)
Cyhoeddwyd: (2025)

Cannot write session to /tmp/vufind_sessions/sess_tef6gksfbcpbifs09kkc2ad3dc